The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis
Open accessAbstract
Background and Purpose— Cilostazol, a phosphodiesterase inhibitor, has been reported to reduce restenosis rate after coronary angioplasty and stenting. This study was performed to investigate the effect of cilostazol on the progression of intracranial arterial stenosis (IAS). Methods— We randomized 135 patients with acute symptomatic stenosis in the M1 segment of middle cerebral artery or the basilar artery to either cilostazol 200 mg per day or placebo for 6 months. Aspirin 100 mg per day was also given to all patients. Patients with potential embolic sources in the heart or extracranial arteries were excluded. IAS was assessed by magnetic resonance angiogram (MRA) and transcranial Doppler (TCD) at the time of recruitment and 6 months later. The primary outcome was the progression of symptomatic IAS on MRA and secondary outcomes were clinical events and progression on TCD. Results— Thirty-eight patients were prematurely terminated. Dropout rates and reasons for dropouts were similar between the cilostazol and placebo groups. There was no stroke recurrence in either cilostazol or placebo group, but there was 1 death and 2 coronary events in each group. In cilostazol group, 3 (6.7%) of 45 symptomatic IAS progressed and 11 (24.4%) regressed. In placebo group, 15 (28.8%) of symptomatic IAS progressed and 8 (15.4%) regressed. Progression of symptomatic IAS in cilostazol group was significantly lower than that in placebo group ( P =0.008) Conclusion— Our study suggests that symptomatic IAS is a dynamic lesion and cilostazol may prevent its progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The EC/IC Bypass Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131904 · Cited by 1,563
Sacco, R. L., Kargman, D. E., Gu, Q., & Zamanillo, M. C. (1995) · Stroke · doi:10.1161/01.str.26.1.14 · Cited by 974
The Warfarin-Aspirin Symptomatic Intracranial Disease Study
Chimowitz, M. I., Kokkinos, J., Strong, J., Brown, M. B., Levine, S. R., Silliman, S., Pessin, M. S., Weichel, E., Sila, C. A., Furlan, A. J., et al. (1995) · Neurology · doi:10.1212/wnl.45.8.1488 · Cited by 621
Chinese‐white differences in the distribution of occlusive cerebrovascular disease
Feldmann, E., Daneault, N., Kwan, E., Ho, K. J., Pessin, M. S., Langenberg, P., & Caplan, L. R. (1990) · Neurology · doi:10.1212/wnl.40.10.1540 · Cited by 356
Gotoh, F., Tohgi, H., Hirai, S., Terashi, A., Fukuuchi, Y., Otomo, E., Shinohara, Y., Itoh, E., Matsuda, T., Sawada, T., et al. (2000) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1053/jscd.2000.7216 · Cited by 343
Shin, H. K., Kim, Y. K., Kim, K. Y., Lee, J. H., & Hong, K. W. (2004) · Circulation · doi:10.1161/01.cir.0000117403.64398.53 · Cited by 268
Self-citationBurgin, W. S., Malkoff, M., Felberg, R. A., Demchuk, A. M., Christou, I., Grotta, J. C., & Alexandrov, A. V. (2000) · Stroke · doi:10.1161/01.str.31.5.1128 · Cited by 242
Tanaka, T., Ishikawa, T., Hagiwara, M., Onoda, K., Itoh, H., & Hidaka, H. (2008) · Pharmacology · doi:10.1159/000138400 · Cited by 186
Takahashi, S., Oida, K., Fujiwara, R., Maeda, H., Hayashi, S., Takai, H., Tamai, T., Nakai, T., & Miyabo, S. (1992) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199212000-00009 · Cited by 182
Stenting of Symptomatic M1 Stenosis of Middle Cerebral Artery
Jiang, W., Wang, Y., Du, B., Wang, S.-X., Wang, G., Jin, M., & Jian-ping, D. (2004) · Stroke · doi:10.1161/01.str.0000128018.57526.3a · Cited by 157
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Kleindorfer, D. O., Towfighi, A., Chaturvedi, S., Cockroft, K. M., Gutierrez, J., Lombardi-Hill, D., Kamel, H., Kernan, W. N., Kittner, S. J., Leira, E. C., et al. (2021) · Stroke · doi:10.1161/str.0000000000000375 · Cited by 3,237
Stroke Caused by Atherosclerosis of the Major Intracranial Arteries
Banerjee, C., & Chimowitz, M. I. (2017) · Circulation Research · doi:10.1161/circresaha.116.308441 · Cited by 437
Wong, K. S. L., Chen, C., Fu, J., Chang, H. M., Suwanwela, N. C., Huang, Y. N., Han, Z., Tan, K. S., Ratanakorn, D., Chollate, P., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70060-0 · Cited by 417
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
Holmes, D. R., Dehmer, G. J., Kaul, S., Leifer, D., O’Gara, P. T., & Stein, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.013 · Cited by 354
Metadata
- Authors
- Kwon, S. U., Cho, Y.-J., Koo, J.-S., Bae, H.-J., Lee, Y.-S., Hong, K.-S., Lee, J. H., & Kim, J. S.
- Venue
- Stroke
- Published
- 2005-04
- Volume
- 36
- Issue
- 4
- Pages
- 782-786
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2133501611
- Cited by
- 306
- References
- 15
- FWCI
- 11.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. https://app.cochat.ai/papers/10.1161/01.str.0000157667.06542.b7
- The paper
- Kwon, S. U., Cho, Y.-J., Koo, J.-S., Bae, H.-J., Lee, Y.-S., Hong, K.-S., Lee, J. H., & Kim, J. S. (2005). Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis. Stroke. https://doi.org/10.1161/01.str.0000157667.06542.b7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.